Genetron | Results Presentation Deck | 23 slides

Genetron · 2021-08
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON

Slide inventory

23
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · Attention
02
other
Open slide detailBeat · Attention
03
The slide uses a pie chart to segment the TAM across three business areas: Biopharma Services, Diagnosis & Monitoring, and Early Screening.size_opportunity
Open slide detailBeat · Attention
04
front_matter
Open slide detailBeat · Attention
05
summarize
Open slide detailBeat · Attention
06
The slide highlights the 'HIT' study results, comparing performance metrics and detection ranges against traditional methods.analyze_data
Open slide detailBeat · NeedLoop · Cost Of Inaction
07
The slide uses a hub-and-spoke diagram to illustrate the commercialization ecosystem.present_solution
Open slide detailBeat · NeedLoop · Cost Of Inaction
08
The chart illustrates the superior sensitivity of NGS (red line) compared to MFC and PCR in detecting malignant cells over time.present_solution
Open slide detailBeat · NeedLoop · Cost Of Inaction
09
The slide highlights the company's role in co-development of drugs and companion diagnostics across the value chain.establish_context
10
The slide combines product hardware (kit + sequencer) with clinical utility (gene mutation rates) and commercial status (CE mark).present_solution
11
front_matter
12
Includes CAGR annotations on the left chart and percentage composition on the right chart.analyze_data
Open slide detailBeat · Satisfaction
13
The slide uses a pyramid to represent the target market segments (Near/Mid/Long-term) and a line chart to show the growth of hospital partners.present_solution
Open slide detailBeat · Satisfaction
14
The slide uses a combination of bar charts for gross profit (RMB million) and line charts for gross margin percentages.analyze_data
Open slide detailBeat · Satisfaction
15
The slide uses a dual-axis approach (bar for absolute value, line for percentage of revenue) to track expense trends.analyze_data
Open slide detailBeat · Satisfaction
16
Includes a footnote regarding Non-IFRS loss definition and a cash position statement at the bottom.analyze_data
Open slide detailBeat · Satisfaction
17
The chart uses 3D stacked bars to represent revenue segments (Development services, LDT, IVD) over time.analyze_data
Open slide detailBeat · Satisfaction
18
front_matter
19
The slide uses a timeline-based roadmap integrated with a patient journey diagram.plan_implementation
Open slide detailBeat · ActionLoop · Why Now
20
Includes a clinical timeline chart and a hub-and-spoke diagram representing the Genetron Precision Oncology Platform.plan_implementation
Open slide detailBeat · ActionLoop · Why Now
21
front_matter
22
The table reconciles 'Loss for the period' to 'Non-IFRS Loss' by adjusting for share-based compensation and fair value loss of financial instruments.analyze_data
23
front_matter